- Home
- FOA vs BWAY Comparison
FOA vs BWAY Comparison
Compare FOA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- BWAY
- Stock Information
- Founded
- FOA 2013
- BWAY 2003
- Country
- FOA United States
- BWAY Israel
- Employees
- FOA N/A
- BWAY N/A
- Industry
- FOA Finance Companies
- BWAY Medical/Dental Instruments
- Sector
- FOA Finance
- BWAY Health Care
- Exchange
- FOA Nasdaq
- BWAY Nasdaq
- Market Cap
- FOA 272.8M
- BWAY 280.7M
- IPO Year
- FOA N/A
- BWAY 2019
- Fundamental
- Price
- FOA $21.50
- BWAY $16.75
- Analyst Decision
- FOA Buy
- BWAY Strong Buy
- Analyst Count
- FOA 2
- BWAY 2
- Target Price
- FOA $27.50
- BWAY $18.00
- AVG Volume (30 Days)
- FOA 119.3K
- BWAY 61.5K
- Earning Date
- FOA 11-04-2025
- BWAY 11-11-2025
- Dividend Yield
- FOA N/A
- BWAY N/A
- EPS Growth
- FOA N/A
- BWAY 679.98
- EPS
- FOA 7.10
- BWAY 0.11
- Revenue
- FOA $527,520,999.00
- BWAY $46,084,000.00
- Revenue This Year
- FOA $21.21
- BWAY $335.63
- Revenue Next Year
- FOA $10.95
- BWAY $22.10
- P/E Ratio
- FOA $3.06
- BWAY $60.12
- Revenue Growth
- FOA 46.94
- BWAY 26.50
- 52 Week Low
- FOA $11.33
- BWAY $7.84
- 52 Week High
- FOA $32.40
- BWAY $17.49
- Technical
- Relative Strength Index (RSI)
- FOA 38.78
- BWAY 62.33
- Support Level
- FOA $22.38
- BWAY $16.44
- Resistance Level
- FOA $23.03
- BWAY $17.49
- Average True Range (ATR)
- FOA 0.74
- BWAY 0.68
- MACD
- FOA 0.09
- BWAY 0.08
- Stochastic Oscillator
- FOA 16.19
- BWAY 74.83
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.